SCHEMBL32686875

SCHEMBL32686875

O=C1c2ccccc2[C@@H](Cc2ncccc2C(F)F)N1Cc1ccc2[nH]c(=O)oc2c1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 3/20 0.37
▸ WDR77 Q9BQA1 3/20 0.37
▸ IL4I1 Q96RQ9 1/20 0.36
▸ MAPK1 P28482 2/20 0.34
▸ HPGD P15428 2/20 0.33
▸ SYK P43405 1/20 0.33
▸ MAPT P10636 3/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ LMNA P02545 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ ATXN2 Q99700 1/20 0.32
▸ PTDSS1 P48651 1/20 0.31
▸ GRIN1 Q05586 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ ENPP2 Q13822 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32686824 1.00 PRMT5 (0.37) PRMT5WDR77IL4I1MAPK1HPGD
SCHEMBL32686756 1.00 PRMT5 (0.37) PRMT5WDR77IL4I1MAPK1HPGD
SCHEMBL31667346 0.92 IL4I1 (0.36) PRMT5WDR77IL4I1MAPK1HPGD
SCHEMBL31667213 0.90 PRMT5 (0.40) PRMT5WDR77IL4I1MAPK1HPGD
SCHEMBL31667119 0.87 IL4I1 (0.37) PRMT5WDR77IL4I1MAPK1HPGD
SCHEMBL31667612 0.87 IL4I1 (0.39) PRMT5WDR77IL4I1MAPK1HPGD
SCHEMBL31667004 0.87 IL4I1 (0.37) PRMT5WDR77IL4I1MAPK1HPGD
SCHEMBL31667349 0.87 IL4I1 (0.39) PRMT5WDR77IL4I1MAPK1HPGD
SCHEMBL31667648 0.87 IL4I1 (0.37) PRMT5WDR77IL4I1MAPK1HPGD
SCHEMBL31667444 0.87 IL4I1 (0.37) PRMT5WDR77IL4I1MAPK1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078130-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF SIRONAX LTD (KY) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078130-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF NAMPT, NNMT, SARM1 PRMT5 981/4885WDR77 2686/4885IL4I1 2872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback